# ClinicalTrials.gov record NCT07029009

> PeptideScanner retained ClinicalTrials.gov record NCT07029009 at 2026-07-30T18:18:33.514Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was liraglutide.

- Evidence object: `story:clinicaltrials-gov-nct07029009-liraglutide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-12-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct07029009-liraglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07029009-liraglutide-v1.json
- Content SHA-256: `820fad17a7fe78a858a2ea083bccc7d990355d1287e8fa849025562e0593f5e4`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT07029009 ([`ctg-observation-nct07029009-2025-12-17-bb3755c07710`](#source-ctg-observation-nct07029009-2025-12-17-bb3755c07710))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT07029009 at 2026-07-30T18:18:33.514Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct07029009-2025-12-17-bb3755c07710`](#source-ctg-observation-nct07029009-2025-12-17-bb3755c07710))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT07029009 at 2026-07-30T18:18:33.514Z. Its registry update date was 2025-12-17, and PeptideScanner's reviewed identity mapping was liraglutide. ([`ctg-observation-nct07029009-2025-12-17-bb3755c07710`](#source-ctg-observation-nct07029009-2025-12-17-bb3755c07710))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct07029009-2025-12-17-bb3755c07710`](#source-ctg-observation-nct07029009-2025-12-17-bb3755c07710))

## Sources

<a id="source-ctg-observation-nct07029009-2025-12-17-bb3755c07710"></a>
- **ClinicalTrials.gov record NCT07029009 · retained source version 2025-12-17:bb3755c0771079f42200d2d2390051aa7a4d4abd5b472d688da3e9a3fbac31af** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT07029009) (`ctg-observation-nct07029009-2025-12-17-bb3755c07710`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT07029009." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct07029009-liraglutide-v1.json SHA-256: 820fad17a7fe78a858a2ea083bccc7d990355d1287e8fa849025562e0593f5e4.